Wegovy Denied by Insurance? How to Appeal and Win

Wegovy Denied by Insurance? How to Appeal and Win

Wegovy has become one of the most prescribed weight management medications in the country. Getting a prescription is often the easy part. Getting a health plan to pay for it is where many patients run into trouble.

The coverage gap is wide. The 2025 KFF Employer Health Benefits Survey found that 57% of large employers still don’t cover GLP-1 drugs for weight loss, and only about 1% of ACA Marketplace formularies include Wegovy. If your claim was rejected, you have a lot of company, and the rejection reflects how plans are designed far more than anything about your health.

A Wegovy denial can feel especially unfair given how much the drug’s clinical profile has grown. Beyond chronic weight management, semaglutide now carries FDA approval for reducing the risk of heart attack, stroke, and cardiovascular death in adults with established heart disease, and for treating MASH with liver fibrosis. No other weight management medication has that cardiovascular indication, which is often part of why a doctor chose it.

Every denial can be appealed, though few patients know that. Fewer than 1% of denied claims are ever challenged, and nearly half of patients simply give up on treatment. Those who do appeal with good documentation win more often than you might guess.

Why Wegovy Gets Denied

Insurers tend to rely on a small set of reasons when they refuse Wegovy, and yours will shape how you respond.

Many denials come from a plan-wide exclusion. The plan has decided not to pay for any anti-obesity medication, a choice driven by cost and applied to everyone regardless of medical history. Wegovy’s broader label matters here, because a plan that excludes weight loss drugs may still cover treatment for cardiovascular disease or liver disease.

Other denials involve step therapy, where the insurer wants you to try less expensive options such as Contrave, Saxenda, or phentermine first. Failing a drug has a broad meaning in this context. Side effects you couldn’t tolerate count, and so does a medical reason you couldn’t take the drug at all.

You may also see a denial stating that Wegovy isn’t on the formulary, that it isn’t medically necessary, or that prior authorization criteria weren’t met. These often trace back to a sparse initial submission, or to criteria the insurer applied incorrectly.

Whatever the reason, start by reading the denial letter closely. By law it must state why coverage was refused, what your appeal rights are, and how long you have to file.

3 Routes to Reversing the Denial

With the reason in hand, you have three main options. They can be used together, and combining them often makes for a stronger case.

1. Ask Your Doctor to Appeal

The route most people know is the provider appeal, in which your prescriber sends the insurer evidence that Wegovy is medically necessary for you.

The core of that submission is a letter of medical necessity. It should describe your diagnosis, your BMI before treatment began, related conditions such as heart disease, sleep apnea, or prediabetes, what you’ve already tried, and why Wegovy specifically is the right fit. Good letters reference the supporting research (the STEP trials for weight management, SELECT for cardiovascular outcomes) and respond to each of the insurer’s criteria in turn.

When the first prior authorization request was light on detail, a fuller submission from your doctor may be enough to change the result. Provider appeals do have limits, though, and may lack some of the protections attached to appeals filed by patients.

2. Submit Your Own Appeal

Patients are often surprised to learn they can appeal on their own behalf. This right exists separately from anything your doctor files.

A patient appeal comes with guaranteed response times, more than one level of review, and the ability to take your case to an independent reviewer outside the insurance company. If your doctor’s attempt has already failed, your own appeal starts a fresh process on a separate track.

A strong patient appeal brings together three things: your own description of how the denial affects your health and day-to-day life, clinical support such as medical records, labs, and published studies, and an explanation of how your case meets the plan’s coverage rules or relevant law.

Filing windows differ. Many commercial plans give you 180 days, but UnitedHealthcare allows only 65 days for many plan types and Medicare Advantage plans allow 60. Find the date in your denial letter and plan around it.

3. Use a Professional Appeal Service

If the process seems like too much to take on, or you’ve lost one round and want experienced help, a professional appeal service can handle it.

Companies like Claimable build appeal packages that pull clinical evidence, policy analysis, and the patient’s own story into one submission written for a specific insurer. Because they work on large numbers of GLP-1 appeals, they’ve learned which arguments work with which payers and when to escalate.

This option suits harder cases in particular, such as blanket exclusions that call for an alternate-indication argument, step therapy disputes, or appeals that have already been turned down. 

What Happens After You File

After you submit, the insurer must answer within 30 days for a standard appeal and within 72 hours for an urgent one.

A denied internal appeal still leaves you with options. You can request an external review, in which an independent third party evaluates the case on its clinical merits. These reviews typically take 45 to 60 days, so the full process often runs 6 to 10 weeks.

You can also file a complaint with your state’s Department of Insurance or, if you have an employer-sponsored ERISA plan, look into further legal options.

Insurers count on most people accepting the first no. Patients who appeal through the right channel with complete documentation do much better than those who don’t.

Whichever route you take, act soon. Deadlines are firm, and a thorough appeal filed early gets you an answer sooner. Your doctor prescribed Wegovy for a clinical reason, and a coverage denial leaves that reason intact. The appeal is your chance to have it properly reviewed.

SHARE THIS ARTICLE


Medigy

Medigy




Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2026 Netspective Foundation, Inc. All Rights Reserved.

Built on Oct 14, 2026 at 6:06pm